Effects of fesoterodine on frequency/volume chart in treatment-naive female patients with overactive bladder in the real-world clinical setting

Effects of fesoterodine on frequency/volume chart in treatment-naive female patients with overactive bladder in the real-world clinical setting - Effects of fesoterodine on frequency/volume chart

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040425

Enrollment

100

Registered

2020-05-20

Start date

2014-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Treatment-naive Japanese female patients who visited the hospital for the symptoms of OAB and were clinically diagnosed with OAB

Exclusion criteria

Exclusion criteria: Patients with urinary tract infection, large postvoid residual volume, a previous treatment history for OAB, and contraindications to use of fesoterodine

Design outcomes

Primary

Measure	Time frame
change of the number of voids	—

Secondary

Measure	Time frame
change of mean voided volume	—

Countries

Japan

Contacts

Public ContactYoshinori Tanaka

Hokkaido Prefectural Esashi Hospital Division of Urology

rinoshiyokanata@me.com0139-52-0036

Outcome results